Literature DB >> 31312368

Cysteine-rich intestinal protein 1 silencing alleviates the migration and invasive capability enhancement induced by excessive zinc supplementation in colorectal cancer cells.

Guoyang He1,2,3, Huifang Zhu1, Yakun Yao1, Huanran Chai1, Yongqiang Wang1, Wenli Zhao1, Suzhen Fu4, Yongxia Wang1.   

Abstract

Cysteine-rich intestinal protein 1 (CRIP1) is overexpressed in colorectal cancer (CRC) tissues and functions as an oncogene in regulating the migration and invasion of CRC cells. However, the underlying mechanism is unclear. CRIP1 has a role in zinc absorption and functions as an intracellular zinc transport protein. Here, we aimed to focus on the function of zinc and its underlying mechanism in CRC and determine whether CRIP1 promotes invasion and CRC metastasis through excessive zinc-induced epithelial-mesenchymal transition (EMT) by affecting the phosphorylated glycogen synthase kinase (GSK)-3beta. The results showed that ZnSO4 (Zn2+) supplementation in medium increased the labile intracellular zinc content. Furthermore, excessive Zn2+ supplementation activated the GSK3/mTOR signaling pathway in both SW620 and LoVo cells, and excessive Zn2+ supplementation promoted migration, invasion, and EMT of SW620 and LoVo cells. This migration promotion was alleviated by the specific mTOR inhibitor rapamycin, indicating that the GSK3/mTOR signaling pathway was involved in this process. CRIP1 silencing increased the labile intracellular zinc content and inhibited EMT and GSK3/mTOR signaling pathway. CRIP1 silencing alleviated the zinc supplementation effects on migration, invasion, EMT, and GSK3/mTOR signaling pathway. In conclusion, excessive Zn2+ promotes migration and invasion capabilities of SW620 and LoVo cells through GSK3/mTOR signaling pathway-induced EMT.

Entities:  

Keywords:  Excessive zinc; cysteine-rich intestinal protein 1; epithelial-mesenchymal transition; migration and invasion capabilities

Year:  2019        PMID: 31312368      PMCID: PMC6614615     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  9 in total

1.  Clinical significance of CD34+CD117dim/CD34+CD117bri myeloblast-associated gene expression in t(8;21) acute myeloid leukemia.

Authors:  Xueping Li; Yuting Dai; Bing Chen; Jinyan Huang; Saijuan Chen; Lu Jiang
Journal:  Front Med       Date:  2021-03-23       Impact factor: 4.592

2.  CRIP1 suppresses BBOX1-mediated carnitine metabolism to promote stemness in hepatocellular carcinoma.

Authors:  Jing Wang; Yan Zhou; Donghui Zhang; Weiyi Zhao; Yishi Lu; Chaoqun Liu; Wandie Lin; Yujie Zhang; Kunling Chen; Hui Wang; Liang Zhao
Journal:  EMBO J       Date:  2022-07-01       Impact factor: 14.012

3.  Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/β-Catenin-Mediated EMT and Tumour Metastasis.

Authors:  Yujuan Liu; Wenyu Li; Ji Luo; Yiguo Wu; Yuanyuan Xu; Tingtao Chen; Wei Zhang; Fen Fu
Journal:  Dis Markers       Date:  2021-08-06       Impact factor: 3.434

4.  Catalpol Protects Against Pulmonary Fibrosis Through Inhibiting TGF-β1/Smad3 and Wnt/β-Catenin Signaling Pathways.

Authors:  Fan Yang; Zhen-Feng Hou; Hao-Yue Zhu; Xiao-Xuan Chen; Wan-Yang Li; Ren-Shuang Cao; Yu-Xuan Li; Ru Chen; Wei Zhang
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

5.  Comprehensive Analysis of CRIP1 in Patients with Ovarian Cancer, including ceRNA Network, Immune-Infiltration Pattern, and Clinical Benefit.

Authors:  Bingli Qi; Shikai Liu; Dantong Liu; Hairong Yao; Ruixue Yan
Journal:  Dis Markers       Date:  2022-01-31       Impact factor: 3.434

Review 6.  The Impact of Zinc and Zinc Homeostasis on the Intestinal Mucosal Barrier and Intestinal Diseases.

Authors:  Yan Wan; Bingkun Zhang
Journal:  Biomolecules       Date:  2022-06-27

7.  Comprehensive Analysis of CRIP1 Expression in Acute Myeloid Leukemia.

Authors:  Yan Gao; Jin-Yuan Li; Jia-Ying Mao; Jia-Fan Zhou; Lu Jiang; Xue-Ping Li
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

8.  Identification of prognostic alternative splicing events in sarcoma.

Authors:  Hongshuai Li; Jie Yang; Guohui Yang; Jia Ren; Yu Meng; Peiyi Qi; Nan Wang
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

9.  CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy.

Authors:  Huiying Sun; Rui Zhou; Yannan Zheng; Zhaowei Wen; Dingling Zhang; Dongqiang Zeng; Jianhua Wu; Zhenhua Huang; Xiaoxiang Rong; Na Huang; Li Sun; Jianping Bin; Yulin Liao; Min Shi; Wangjun Liao
Journal:  Oncogene       Date:  2021-07-14       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.